LEHI, Utah & PLANO, Texas–(BUSINESS WIRE)– #healthsystems–Solutionreach, the leader in patient relationship management software, and DoctorLogic, the premier website marketing and patient acquisition platform, today announce a partnership that expan…
Author: Business Wire
National Vision’s “Made Locally, Given Globally” Charitable Program Surpasses 100,000 Eyeglass Donations
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, today announced that its philanthropic outreach program, “Made Locally, Given …
Foster Grant Releases Key Summer Trends in Eyewear
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, a leading eyewear designer and marketer, and Foster Grant®, its globally recognized eyewear brand, announce the top summer trends for eyewear, across multiple categories. Trend research teams at FGX…
NextGen® Revenue Cycle Management Services Adopted by Palmetto Retina Center
ATLANTA–(BUSINESS WIRE)—- $NXGN #AmbulatoryHealthcare–Leading Eyecare and Surgery Center Leverages NextGen® RCM Services to Improve Financial Performance and Enhance Patient Experience
Aerie Pharmaceuticals Announces Appointment of Frank Estrada, Ed.D., as Director, Salesforce Training
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Aerie Pharmaceuticals to Participate in the Raymond James Human Health Innovation Conference – UPDATED RELEASE
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Ciba Vision Johor Sdn. Bhd. also known as ALCON Johor earns the best place to work certification in Malaysia for 2021
KUALA LUMPUR, Malaysia–(BUSINESS WIRE)–Alcon Johor, an affiliate of the largest eye care device company in the world with 75 years heritage, present in over 70 countries and serving patients in more than 140 countries by over 23,000 associates, has b…
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
Wet (Neovascular / Exudative) Macular Degeneration – Global Clinical Trials Review, H1, 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Wet (Neovascular / Exudative) Macular Degeneration – Global Clinical Trials Review, H1, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. “Wet (Neovascular / Exudative) Macular Degeneration – Globa…
Zion Eye Institute Enters Partnership with Comprehensive EyeCare Partners
LAS VEGAS & ST. GEORGE, Utah–(BUSINESS WIRE)–Comprehensive EyeCare Partners, one of the largest vision care practice management organizations in the nation, is pleased to announce a strategic partnership with Zion Eye Institute, a leading ophthalmic …
LENZ Therapeutics Debuts With $47 Million Series A Financing
SAN DIEGO–(BUSINESS WIRE)–LENZ Therapeutics, a biopharmaceutical company with a lead late clinical-stage program that represents a potential best-in-class therapy for presbyopia, today emerged from stealth mode with a $47 million Series A financing f…
PanOptica Announces Licensing Agreement with Zhaoke Ophthalmology for PAN-90806 for the Treatment of Neovascular Eye Diseases in China, South Korea, and Southeast Asia
MOUNT ARLINGTON, N.J.–(BUSINESS WIRE)–PanOptica confirms the licensing agreement with Zhaoke Ophthalmology to develop and commercialize PAN-90806 in China, South Korea, and Southeast Asia.
Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the formation of a new, urologic oncology fo…
Global Thyroid Eye Disease (TED) Clinical Landscape Market Report 2021: Marketed and Pipeline Drugs, Trials, Key Events, Probability Of Success, 10-Year Disease Prevalence Forecast, Deals, Revenue – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Thyroid Eye Disease (TED)” report has been added to ResearchAndMarkets.com’s offering. Thyroid eye disease (TED), also called Graves’ ophthalmopathy or orbitopathy, is an autoimmune disorder that causes i…
$16+ Billion Sunglasses Global Market to 2027 – Opportunity Analysis and Industry Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Sunglasses Market by Type, Design, Frame Material and Distribution Channel: Global Opportunity Analysis and Industry Forecast 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The global sunglasses mar…
DTx Pharma to Participate in the 2021 BMO BioPharma Day: Spotlight on Rare Disease and Ophthalmology
SAN DIEGO–(BUSINESS WIRE)– #BMO–DTx Pharma to participate in the 2021 BMO BioPharma Day: Spotlight on Rare Disease and Ophthalmology
Sunvera Group Announces New Partnership with TruVista Surgery Center
BINGHAM FARMS, Mich.–(BUSINESS WIRE)–Sunvera Expands Detroit Presence
DeepOptics Debuts First-ever Adaptive Focus Sunglasses as Silicon Valley Tech Companies Race to Put Smartglasses on Consumers
TEL AVIV, Israel–(BUSINESS WIRE)– #32N–DeepOptics launches Kickstarter campaign for 32°N, the stylish sunglasses with tunable lenses that switch to reading glasses.
Arnaud Lacoste Is Named Chief Scientific Officer of Aurion Biotech
SEATTLE & BOSTON & TOKYO–(BUSINESS WIRE)–Arnaud Lacoste joins Aurion Biotech as chief scientific officer.
VisionQuest Uses Artificial Intelligence to Screen 40,000 Patients for Diabetic Retinopathy
ALBUQUERQUE, New Mexico–(BUSINESS WIRE)– #ai–VisionQuest Biomedical Inc. announces that the company has used the EyeStar artificial intelligence (AI) software to screen over 40,000 patients for diabetic retinopathy at the Clínicas del Azúcar. The Ey…